…
DNA X, Inc. provides cryptocurrency trading services worldwide. The company operates a cryptocurrency trading platform that allows users to trade and swap cryptocurrencies for other cryptocurrencies or cash-equivalent currencies. It markets its services through word of mouth and earned media on social media platforms. The company serves individual cryptocurrency traders. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -7.96M | -33.42M | 0.28M | -13.90M | -38.46M |
| Net income | -20.66M | -33.65M | -0.09M | -14.09M | -38.63M |
| Selling general administrative | 5.41M | 12.38M | 8.27M | 10.67M | 17.15M |
| Selling and marketing expenses | - | 12.96M | 8.77M | 7.27M | 9.57M |
| Gross profit | -4.30M | 9.92M | 19.32M | 11.62M | 6.41M |
| Reconciled depreciation | 4.30M | 3.56M | 3.07M | 2.38M | 2.13M |
| Ebit | -6.47M | -33.39M | 0.30M | -14.29M | -38.00M |
| Ebitda | -2.17M | -29.84M | 2.50M | -11.43M | -36.33M |
| Depreciation and amortization | 4.30M | 3.56M | 2.21M | 2.86M | 1.67M |
| Operating income | -5.41M | -33.64M | 0.51M | -14.29M | -38.00M |
| Other operating expenses | 5.41M | 91.94M | 93.12M | 84.12M | 92.57M |
| Interest expense | 1.49M | 0.03M | 0.01M | 0.10M | 0.46M |
| Tax provision | 0.00M | 0.23M | 0.26M | 0.18M | 0.17M |
| Net interest income | -1.49M | -0.03M | -0.01M | -0.10M | 0.00M |
| Income tax expense | - | 0.23M | 0.37M | 0.18M | 0.17M |
| Total revenue | 0.00M | 58.30M | 93.63M | 69.83M | 54.57M |
| Total operating expenses | 1.11M | 43.56M | 18.81M | 25.91M | 44.41M |
| Cost of revenue | 4.30M | 48.38M | 74.31M | 58.20M | 48.16M |
| Total other income expense net | -2.55M | 0.22M | -0.23M | 0.39M | -0.46M |
| Net income from continuing ops | -7.96M | -33.65M | 0.22M | -14.09M | -38.63M |
| Net income applicable to common shares | - | - | - | -14.09M | -38.63M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 43.90M | 39.74M | 56.04M | 53.69M | 41.09M |
| Other current assets | 27.61M | 4.56M | 1.61M | 0.77M | 1.49M |
| Total liab | 50.62M | 45.44M | 33.67M | 33.64M | 22.46M |
| Total stockholder equity | -6.73M | -5.70M | 22.37M | 20.05M | 18.63M |
| Deferred long term liab | - | - | - | 6.85M | 2.35M |
| Other current liab | 36.33M | 19.19M | 12.23M | 9.73M | 11.35M |
| Common stock | 1.23M | 0.01M | 0.04M | 0.04M | 0.02M |
| Capital stock | 1.23M | 0.01M | 0.04M | 0.04M | 0.02M |
| Retained earnings | -304.26M | -283.61M | -249.96M | -249.87M | -234.81M |
| Other liab | - | - | - | 1.58M | 1.41M |
| Other assets | - | - | - | 9.82M | 4.87M |
| Cash | 1.30M | 5.34M | 9.40M | 13.21M | 11.23M |
| Total current liabilities | 48.03M | 43.74M | 32.15M | 32.06M | 20.98M |
| Current deferred revenue | - | - | 0.01M | 0.03M | 0.01M |
| Net debt | 3.76M | -5.34M | -9.34M | -13.00M | -11.02M |
| Short term debt | 5.07M | - | 0.06M | 0.21M | 0.15M |
| Short long term debt | 5.07M | - | - | 0.15M | 0.15M |
| Short long term debt total | 5.07M | - | 0.06M | 0.21M | 0.21M |
| Other stockholder equity | 296.31M | 277.90M | 272.29M | 269.87M | 253.42M |
| Property plant equipment | - | - | - | 0.23M | 0.53M |
| Total current assets | 28.91M | 32.16M | 43.79M | 43.63M | 35.69M |
| Long term investments | 1.24M | 0.00M | - | - | - |
| Net tangible assets | - | - | - | 20.05M | 18.63M |
| Net receivables | - | 11.64M | 26.27M | 24.75M | 14.75M |
| Long term debt | - | - | - | - | 0.07M |
| Inventory | - | 10.62M | 6.52M | 3.91M | 5.54M |
| Accounts payable | 4.03M | 22.85M | 19.85M | 22.09M | 9.47M |
| Accumulated other comprehensive income | - | - | 0.00M | - | - |
| Non currrent assets other | 12.31M | 7.35M | 12.13M | 9.82M | 4.87M |
| Non current assets total | 14.99M | 7.57M | 12.26M | 10.05M | 5.40M |
| Capital lease obligations | - | - | 0.06M | 0.07M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.21M | -0.03M | -0.01M | -0.05M |
| Change to liabilities | - | - | - | 11.67M | 0.62M |
| Total cashflows from investing activities | - | -0.21M | -0.04M | -0.01M | -0.05M |
| Net borrowings | 5.82M | 0.59M | -0.15M | -0.07M | -0.15M |
| Total cash from financing activities | 19.49M | 4.65M | 0.27M | 14.35M | 27.61M |
| Change to operating activities | - | - | - | -3.02M | -2.75M |
| Net income | -20.66M | -33.65M | -0.09M | -14.09M | -38.63M |
| Change in cash | -4.04M | -4.05M | -3.82M | 1.98M | -10.91M |
| Begin period cash flow | 5.34M | 9.40M | 13.21M | 11.23M | 22.14M |
| End period cash flow | 1.30M | 5.34M | 9.40M | 13.21M | 11.23M |
| Total cash from operating activities | -23.53M | -8.49M | -4.05M | -12.36M | -38.48M |
| Issuance of capital stock | 13.67M | 4.01M | 0.00M | 14.41M | 27.70M |
| Depreciation | 4.30M | 3.54M | 2.21M | 2.38M | 2.13M |
| Other cashflows from investing activities | - | -0.21M | - | - | - |
| Change to inventory | 3.85M | -4.99M | -2.61M | 1.63M | 4.18M |
| Change to account receivables | -19.50M | -6.11M | -1.72M | -11.63M | -7.52M |
| Other cashflows from financing activities | 19.49M | 0.05M | 0.42M | -0.01M | 0.06M |
| Change to netincome | - | - | - | 0.68M | 3.32M |
| Capital expenditures | 0.00M | 0.21M | 0.04M | 0.01M | 0.05M |
| Change in working capital | -5.09M | 10.30M | -8.31M | -1.33M | -5.30M |
| Stock based compensation | 1.54M | 1.52M | 1.50M | 1.55M | 1.08M |
| Other non cash items | -3.62M | 9.79M | 0.64M | -0.87M | 2.27M |
| Free cash flow | -23.53M | -8.70M | -4.09M | -12.37M | -38.52M |
Sector: Financial Services Industry: Capital Markets
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SONM DNA X, Inc. |
-0.17 7.39% |
2.13 | - | 3.17 | 0.03 | 0.74 | 0.13 | 6.41 |
| GS Goldman Sachs Group Inc |
-3.13 0.36% |
865.82 | 17.21 | 16.00 | 4.47 | 2.26 | 11.15 | - |
| SCHW Charles Schwab Corp |
-1.09 1.18% |
91.49 | 19.53 | 13.89 | 7.16 | 4.22 | 8.80 | - |
| MS Morgan Stanley |
-1.00 0.55% |
181.44 | 16.50 | 13.76 | 2.80 | 1.65 | - | - |
| IBKR Interactive Brokers Group Inc |
- -% |
75.82 | 35.95 | 27.93 | 22.14 | 6.96 | 3.01 | 3.37 |
DNA X, Inc. provides cryptocurrency trading services worldwide. The company operates a cryptocurrency trading platform that allows users to trade and swap cryptocurrencies for other cryptocurrencies or cash-equivalent currencies. It markets its services through word of mouth and earned media on social media platforms. The company serves individual cryptocurrency traders. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter Hao Liu | CEO & Director | 1968 |
| Mr. Clay Crolius | Chief Financial & Accounting Officer | 1962 |
| Mr. Joseph T. Hooks | Chief People Officer & Chief Admin. Officer | NA |
| Stephanie Sogawa | Legal Counsel | NA |
| Mr. Bengt Jonassen | Sr. VP of Engineering | 1964 |
| Katie Smith | Chief of Staff | NA |
| Mr. Hao Liu | CEO & Director | 1968 |
| Mr. Clayton Crolius | Chief Financial Officer | 1962 |
| Mr. Charles Becher | Chief Commercial Officer & GM of North America | 1968 |
| Mr. Simon Rayne | Senior VP and GM of the UK, EMEA & APAC | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.